Sign inJoin waitlistJoin the waitlist

Tsontcho Ianchulev

Director of Ophthalmic Innovation and Technology · New York Eye and Ear Infirmary of Mount Sinai

Credentials: · · · · ·

History

Icahn School of Medicine at Mount Sinai
Present

University of California Los Angelese
2000–2003
Lahey Hospital & Medical Center
1999–2000
Harvard Medical School
1995–1999

Research

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study
Ophthalmology · 2009 · 1,136 citations
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1
American Journal of Ophthalmology · 2008 · 667 citations
A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration
Ophthalmology · 2009 · 273 citations

Iqbal Ahmed
11 papers
MP
Mark Packer
6 papers
Rachel Aviv
6 papers · 6 as a resident
Robert Weinreb
5 papers
DC
David Chang
4 papers
Gautam Kamthan
4 papers
Louis Pasquale
4 papers
Robert Stamper
4 papers
SL
Shan Lin
4 papers
Brian Francis
3 papers
DB
David Boyer
3 papers
DB
David Brown
3 papers · 3 as a resident

Clinical trials

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes
Study chair · Active not recruiting
Iantrek, Inc.
2022–2027
Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults
Study chair · Completed · Phase 3
Eyenovia Inc.
2020–2021
CyPass Clinical Experience Study
Study director · Completed
Transcend Medical, Inc.
2009–2015